(Q42789462)

7 November 2017

Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists (English)

1 reference

7 November 2017

2

1 reference

7 November 2017

3

Dick van Soolingen

1 reference

7 November 2017

Reinout M Swart

1

1 reference

7 November 2017

Rob Slingerland

series ordinal

4

1 reference

7 November 2017

Willem D H Hendriks

series ordinal

5

1 reference

7 November 2017

Jan G den Hollander

series ordinal

6

1 reference

7 November 2017

1 October 2009

1 reference

Emerging Infectious Diseases

7 November 2017

1 reference

7 November 2017

15

1 reference

7 November 2017

10

1 reference

7 November 2017

1700-1701

1 reference

Mycobacterial disease in patients with rheumatic disease

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Mycobacterium haemophilum infection after alemtuzumab treatment.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

Mycobacterium haemophilum in immunocompromised patients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2866388

16 August 2018

Identifiers

DOI

10.3201/EID1510.090110

1 reference

7 November 2017

1 reference

7 November 2017

1 reference